REVIEW Ponazuril is a triazinedione drug approved for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. It has also been used in smaller animals against coccidia.
Ponazuril is a triazinedione drug currently approved for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite.
Kennedy, Thomas J. Triazineone compounds for treating diseases due to Sarcosystis, Neospora and Toxoplasma PCT Int. Appl. (2000), WO 2000037063 A2 20000629.
Gottstein B, Eperon S, Dai WJ, Cannas A, Hemphill A, Greif G. Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice. Parasitol Res. 2001 Jan;87(1):43-8.
Kritzner S, Sager H, Blum J, Krebber R, Greif G, Gottstein B.An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Ann Clin Microbiol Antimicrob. 2002 Oct 18;1:4.